utilized RN168, a monoclonal antibody targeting the IL7Rα, in patients of T1DM, and observed that RN168 selectively hindered the survival and function of memory T cells, while maintaining the populations of naive T cells and Tregs (51). Here, IL7R is linked to type 1 diabetes mellitus.